Ohio State Navbar


Charles Shapiro, MD

Current OSU Appointments

  • Professor, Internal Medicine, College of Medicine
  • Director of Breast Medical Oncology, James Cancer Hospital and Solove Research Institute
  • Program Leader, Breast Research, The Ohio State Unviersity Comprehesive Cancer Center

Education and Training

  • Bachelor of Science, State University of New York
  • M.D., State University of New York
  • Internal Medicine Residency, Temple University Hospital
  • Medical Oncology Fellowship, Dana-Farber Cancer Institute
Dr. Shapiro joined the Division of Solid Tumor Oncology in 1998. He is a nationally known clinical-translational investigator and  developed the breast medical oncology service with innovative investigator-initiated trials, recruited 6 dedicated breast medical oncologists, developed a breast cancer fellowship program that prepares fellows for independent careers in clinical/translational investigation, successfully mentored fellows and junior faculty and is Section Chief for Breast Cancer in the Division of Oncology.  His long-standing research interests include the side effects of adjuvant treatment for breast cancer, in particular chemotherapy-induced ovarian failure and bone loss, and the development of novel therapeutics in breast cancer. He has led large Cooperative Group trials and published a number of investigator-initiated phase I and II trials. He also leads the Breast Cancer Research Program and has several ongoing collaborations with lab-based researchers in the areas of triple negative breast cancer, new drug development and tumor microenvironment. He has recently been appointed as chair-elect of the ASCO Survivorship Committee, is member of NCI Steering Committee on Symptom Intervention and Health Related Quality of Life, has led the CAGLB Symptom Intervention Committee and served as Director of the Lance Armstrong Survivorship Center of Excellence at James Cancer Hospital.  Dr. Shapiro provides clinical care to women with all stages of invasive breast cancer  for over 22 years.  He is recognized as America’s Top Doctor for Cancer since 2005 and America’s Top Doctors since 2001.